The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of real-world (RW) data for metastatic breast cancer (mBC) patients (pts) with somatic BRCA1/2 (sBRCA) or other homologous recombination (HR)-pathway gene mutations (muts) treated with PARP inhibitors (PARPi).
 
Felipe Batalini
Consulting or Advisory Role - Curio Science
 
Russell Madison
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Dean C. Pavlick
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Ethan Sokol
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Tamara Snow
Employment - Flatiron Health
Stock and Other Ownership Interests - Roche
 
Arjun Sondhi
Employment - Flatiron Health
Stock and Other Ownership Interests - Roche
 
Garrett M. Frampton
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Colby Jenkins
No Relationships to Disclose
 
Judy Ellen Garber
Consulting or Advisory Role - Aleta BioTherapeutics (I); GTx (I); H3 Biomedicine (I); Helix BioPharma; Konica Minolta; Kronos Bio (I); Novartis (I)
Research Funding - Ambry Genetics; InVitae; Myriad Genetics; Novartis (I)
Other Relationship - AACR; Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Facing our Risk of Cancer Empowered; James P. Wilmot Foundation (I); Susan G. Komen for the Cure (I)
 
Gerburg M. Wulf
Stock and Other Ownership Interests - Selecta Biosciences (I)
Research Funding - GlaxoSmithKline (Inst); Merck
Patents, Royalties, Other Intellectual Property - Pin1 as a marker for abnormal cell growth Patent number: 8129131
 
Jeffrey Michael Venstrom
Employment - Foundation Medicine; Genentech
Leadership - Genentech
Stock and Other Ownership Interests - Genentech
Research Funding - Foundation Medicine; Genentech/Roche
Travel, Accommodations, Expenses - Genentech; Genentech
 
Nadine M. Tung
Research Funding - AstraZeneca (Inst)
 
Emily Castellanos
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health; Roche
 
Alexa Betzig Schrock
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine; Roche
 
Kimberly McGregor
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche/Genentech